CTI Biopharma Corp banner
C

CTI Biopharma Corp
F:CEPS

Watchlist Manager
CTI Biopharma Corp
F:CEPS
Watchlist
Price: 28 EUR Market Closed
Market Cap: €3.7B

Wall St Price Targets

CEPS Price Targets Summary
CTI Biopharma Corp

There are no price targets for CEPS.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
CTI Biopharma Corp Competitors:
Price Targets
ZNTL
Zentalis Pharmaceuticals Inc
61% Upside
AMAL
Amalgamated Bank
11% Upside
ISSC
Innovative Solutions and Support Inc
64% Upside

Revenue
Forecast

-1% / Year
Past Growth
-35% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-1% / Year
Past Growth
-35% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 8 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 4 years is -35%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Operating Income Forecast
is not available for CTI Biopharma Corp

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Net Income Forecast
is not available for CTI Biopharma Corp
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CEPS's stock price target?
Not Available

CEPS does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for CTI Biopharma Corp?
Projected CAGR
-35%

Over the last 8 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 4 years is -35%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett